Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
HERPUD1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1, transcript variant 1 |
FXC00371
|
FHC00371
|
FNC00371N
|
FNC00371C
|
GANAB |
glucosidase, alpha; neutral AB, transcript variant 6 |
FXC00404
|
FHC00404
|
FNC00404N
|
FNC00404C
|
MBTPS1 |
membrane-bound transcription factor peptidase, site 1 |
FXC00405
|
FHC00405
|
FNC00405N
|
FNC00405C
|
DDOST |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) |
FXC00413
|
FHC00413
|
FNC00413N
|
FNC00413C
|
EDEM1 |
ER degradation enhancer, mannosidase alpha-like 1 |
FXC00461
|
FHC00461
|
FNC00461N
|
FNC00461C
|
EIF2AK1 |
eukaryotic translation initiation factor 2-alpha kinase 1, transcript variant 1 |
FXC00817
|
FHC00817
|
FNC00817N
|
FNC00817C
|
NPLOC4 |
nuclear protein localization 4 homolog (S. cerevisiae) |
FXC00853
|
FHC00853
|
FNC00853N
|
FNC00853C
|
SYVN1 |
synovial apoptosis inhibitor 1, synoviolin |
FXC00924
|
FHC00924
|
FNC00924N
|
FNC00924C
|
IQGAP1 |
IQ motif containing GTPase activating protein 1 |
FXC01050
|
FHC01050
|
FNC01050N
|
FNC01050C
|
BCL2 |
B-cell CLL/lymphoma 2, transcript variant alpha |
FXC01250
|
FHC01250
|
FNC01250N
|
FNC01250C
|
HYOU1 |
hypoxia up-regulated 1, transcript variant 1 |
FXC01320
|
FHC01320
|
FNC01320N
|
FNC01320C
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
FXC01323
|
FHC01323
|
FNC01323N
|
FNC01323C
|
DNAJC3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
FXC01330
|
FHC01330
|
FNC01330N
|
FNC01330C
|
CALR |
calreticulin |
FXC01453
|
FHC01453
|
FNC01453N
|
FNC01453C
|
PLAA |
phospholipase A2-activating protein |
FXC01474
|
FHC01474
|
FNC01474N
|
FNC01474C
|
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
FXC01530
|
FHC01530
|
FNC01530N
|
FNC01530C
|
EDEM3 |
ER degradation enhancer, mannosidase alpha-like 3 |
FXC01540
|
FHC01540
|
FNC01540N
|
FNC01540C
|
VCP |
valosin containing protein |
FXC01558
|
FHC01558
|
FNC01558N
|
FNC01558C
|
RRBP1 |
ribosome binding protein 1
|
FXC01689
|
FHC01689
|
|
|
CAPN1 |
calpain 1, (mu/I) large subunit, transcript variant 2 |
FXC01739
|
FHC01739
|
FNC01739N
|
FNC01739C
|
SKP1 |
S-phase kinase-associated protein 1, transcript variant 2 |
FXC01803
|
FHC01803
|
FNC01803N
|
FNC01803C
|
HSP90AB1 |
heat shock protein 90kDa alpha (cytosolic), class B member 1, transcript variant 2 |
FXC01815
|
FHC01815
|
FNC01815N
|
FNC01815C
|
CAPN2 |
calpain 2, (m/II) large subunit, transcript variant 1 |
FXC01819
|
FHC01819
|
FNC01819N
|
FNC01819C
|
PRKCSH |
protein kinase C substrate 80K-H, transcript variant 2 |
FXC01870
|
FHC01870
|
FNC01870N
|
FNC01870C
|
MBTPS2 |
membrane-bound transcription factor peptidase, site 2 |
FXC01877
|
FHC01877
|
FNC01877N
|
FNC01877C
|
DNAJB1 |
DnaJ (Hsp40) homolog, subfamily B, member 1, transcript variant 1 |
FXC02189
|
FHC02189
|
FNC02189N
|
FNC02189C
|
WBP1 |
WW domain binding protein 1 |
FXC02661
|
FHC02661
|
FNC02661N
|
FNC02661C
|
SSR4 |
signal sequence receptor, delta, transcript variant 2 |
FXC02757
|
FHC02757
|
FNC02757N
|
FNC02757C
|
BAG2 |
BCL2-associated athanogene 2 |
FXC02815
|
FHC02815
|
FNC02815N
|
FNC02815C
|
XBP1 |
X-box binding protein 1, transcript variant 1 |
FXC03159
|
FHC03159
|
FNC03159N
|
FNC03159C
|
SIL1 |
SIL1 nucleotide exchange factor, transcript variant 2 |
FXC03431
|
FHC03431
|
FNC03431N
|
FNC03431C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
RPN1 |
ribophorin I |
FXC03598
|
FHC03598
|
FNC03598N
|
FNC03598C
|
ATF6B |
activating transcription factor 6 beta, transcript variant 1 |
FXC03600
|
FHC03600
|
FNC03600N
|
FNC03600C
|
P4HB |
prolyl 4-hydroxylase, beta polypeptide |
FXC03733
|
FHC03733
|
FNC03733N
|
FNC03733C
|
PARK2 |
parkin RBR E3 ubiquitin protein ligase, transcript variant 1 |
FXC03885
|
FHC03885
|
FNC03885N
|
FNC03885C
|
ATF4 |
activating transcription factor 4, transcript variant 1 |
FXC04200
|
FHC04200
|
FNC04200N
|
FNC04200C
|
BCAP31 |
B-cell receptor-associated protein 31, transcript variant 2 |
FXC04675
|
FHC04675
|
FNC04675N
|
FNC04675C
|
CUL1 |
cullin 1 |
FXC04681
|
FHC04681
|
FNC04681N
|
FNC04681C
|
DNAJB11 |
DnaJ (Hsp40) homolog, subfamily B, member 11 |
FXC04802
|
FHC04802
|
FNC04802N
|
FNC04802C
|
EIF2AK4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
FXC04866
|
FHC04866
|
FNC04866N
|
FNC04866C
|
FBXO2 |
F-box protein 2 |
FXC04998
|
FHC04998
|
FNC04998N
|
FNC04998C
|
DDIT3 |
DNA-damage-inducible transcript 3, transcript variant 5 |
FXC06075
|
FHC06075
|
FNC06075N
|
FNC06075C
|
NFE2L2 |
nuclear factor, erythroid 2-like 2, transcript variant 1 |
FXC06144
|
FHC06144
|
FNC06144N
|
FNC06144C
|
PPP1R15A |
protein phosphatase 1, regulatory subunit 15A |
FXC06456
|
FHC06456
|
FNC06456N
|
FNC06456C
|
PREB |
prolactin regulatory element binding |
FXC06476
|
FHC06476
|
FNC06476N
|
FNC06476C
|
RBX1 |
ring-box 1, E3 ubiquitin protein ligase |
FXC06613
|
FHC06613
|
FNC06613N
|
FNC06613C
|
RNF5 |
ring finger protein 5, E3 ubiquitin protein ligase |
FXC06671
|
FHC06671
|
FNC06671N
|
FNC06671C
|
OTUB1 |
OTU deubiquitinase, ubiquitin aldehyde binding 1 |
FXC06978
|
FHC06978
|
FNC06978N
|
FNC06978C
|
SSR1 |
signal sequence receptor, alpha, transcript variant 1 |
FXC06995
|
FHC06995
|
FNC06995N
|
FNC06995C
|
TANK |
TRAF family member-associated NFKB activator, transcript variant 1 |
FXC07067
|
FHC07067
|
FNC07067N
|
FNC07067C
|
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 |
FXC07265
|
FHC07265
|
FNC07265N
|
FNC07265C
|
UFD1L |
ubiquitin fusion degradation 1 like (yeast), transcript variant 1 |
FXC07280
|
FHC07280
|
FNC07280N
|
FNC07280C
|
OS9 |
osteosarcoma amplified 9, endoplasmic reticulum lectin, transcript variant 2 |
FXC07885
|
FHC07885
|
FNC07885N
|
FNC07885C
|
HSPBP1 |
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1, transcript variant 1 |
FXC07965
|
FHC07965
|
FNC07965N
|
FNC07965C
|
PDIA6 |
protein disulfide isomerase family A, member 6, transcript variant 4 |
FXC07980
|
FHC07980
|
FNC07980N
|
FNC07980C
|
EIF2S1 |
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
FXC08071
|
FHC08071
|
FNC08071N
|
FNC08071C
|
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6, transcript variant 2 |
FXC08074
|
FHC08074
|
FNC08074N
|
FNC08074C
|
BAK1 |
BCL2-antagonist/killer 1 |
FXC08191
|
FHC08191
|
FNC08191N
|
FNC08191C
|
DAD1 |
defender against cell death 1 |
FXC08323
|
FHC08323
|
FNC08323N
|
FNC08323C
|
IRF1 |
interferon regulatory factor 1 |
FXC08430
|
FHC08430
|
FNC08430N
|
FNC08430C
|
WFS1 |
Wolfram syndrome 1 (wolframin), transcript variant 1 |
FXC09316
|
FHC09316
|
FNC09316N
|
FNC09316C
|
LMAN1 |
lectin, mannose-binding, 1 |
FXC09408
|
FHC09408
|
FNC09408N
|
FNC09408C
|
TRAF2 |
TNF receptor-associated factor 2 |
FXC09417
|
FHC09417
|
FNC09417N
|
FNC09417C
|
ATXN3 |
ataxin 3 |
FXC09491
|
FHC09491
|
FNC09491N
|
FNC09491C
|
CANX |
calnexin, transcript variant 1 |
FXC09834
|
FHC09834
|
FNC09834N
|
FNC09834C
|
RPN2 |
ribophorin II, transcript variant 1
|
FXC09836
|
FHC09836
|
|
|
STUB1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase, transcript variant 1 |
FXC09916
|
FHC09916
|
FNC09916N
|
FNC09916C
|
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
FXC10475
|
FHC10475
|
FNC10475N
|
FNC10475C
|
PDIA3 |
protein disulfide isomerase family A, member 3 |
FXC10503
|
FHC10503
|
FNC10503N
|
FNC10503C
|
SEC13 |
SEC13 homolog, nuclear pore and COPII coat complex component, transcript variant 3 |
FXC10584
|
FHC10584
|
FNC10584N
|
FNC10584C
|
BAX |
BCL2-associated X protein, transcript variant beta |
FXC10662
|
FHC10662
|
FNC10662N
|
FNC10662C
|
SEC61G |
Sec61 translocon gamma subunit, transcript variant 2 |
FXC10872
|
FHC10872
|
FNC10872N
|
FNC10872C
|
CRYAB |
crystallin, alpha B, transcript variant 1 |
FXC11062
|
FHC11062
|
FNC11062N
|
FNC11062C
|
UBE4B |
ubiquitination factor E4B, transcript variant 2 |
FXC11085
|
FHC11085
|
FNC11085N
|
FNC11085C
|
SEC61A1 |
Sec61 translocon alpha 1 subunit |
FXC11190
|
FHC11190
|
FNC11190N
|
FNC11190C
|
MAP2K7 |
mitogen-activated protein kinase kinase 7, transcript variant 3 |
FXC11270
|
FHC11270
|
FNC11270N
|
FNC11270C
|
SAR1A |
secretion associated, Ras related GTPase 1A, transcript variant 2 |
FXC11368
|
FHC11368
|
FNC11368N
|
FNC11368C
|
DLD |
dihydrolipoamide dehydrogenase, transcript variant 1 |
FXC11556
|
FHC11556
|
FNC11556N
|
FNC11556C
|
UBXN6 |
UBX domain protein 6, transcript variant 2 |
FXC14436
|
FHC14436
|
FNC14436N
|
FNC14436C
|
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2, transcript variant 2 |
FXC20012
|
FHC20012
|
FNC20012N
|
FNC20012C
|
FBXO6 |
F-box protein 6 |
FXC20082
|
FHC20082
|
FNC20082N
|
FNC20082C
|
NR0B2 |
nuclear receptor subfamily 0, group B, member 2 |
FXC20160
|
FHC20160
|
FNC20160N
|
FNC20160C
|
ATF6 |
activating transcription factor 6 |
FXC20682
|
FHC20682
|
FNC20682N
|
FNC20682C
|
EIF2AK2 |
eukaryotic translation initiation factor 2-alpha kinase 2, transcript variant 1 |
FXC20967
|
FHC20967
|
FNC20967N
|
FNC20967C
|
EIF2AK2 |
eukaryotic translation initiation factor 2-alpha kinase 2, transcript variant 3 |
FXC20968
|
FHC20968
|
FNC20968N
|
FNC20968C
|
DNAJB2 |
DnaJ (Hsp40) homolog, subfamily B, member 2, transcript variant 2 |
FXC21328
|
FHC21328
|
FNC21328N
|
FNC21328C
|
DERL1 |
derlin 1, transcript variant 1 |
FXC23373
|
FHC23373
|
FNC23373N
|
FNC23373C
|
ERO1L |
endoplasmic reticulum oxidoreductase alpha
|
FXC25170
|
FHC25170
|
|
|
AMFR |
autocrine motility factor receptor, E3 ubiquitin protein ligase |
FXC25706
|
FHC25706
|
FNC25706N
|
FNC25706C
|
CRYAA |
crystallin, alpha A |
FXC27200
|
FHC27200
|
FNC27200N
|
FNC27200C
|
UBE2G2 |
ubiquitin-conjugating enzyme E2G 2, transcript variant 1 |
FXC27206
|
FHC27206
|
FNC27206N
|
FNC27206C
|
UBE2G1 |
ubiquitin-conjugating enzyme E2G 1 |
FXC28418
|
FHC28418
|
FNC28418N
|
FNC28418C
|